Industry Research Reports

Home > Reports > Pharma & Healthcare > Global Antimicrobial Peptides Market Report, History and Forecast 2018-2029, Breakdown Data by Manufacturers, Key Regions, Types and Application

Global Antimicrobial Peptides Market Report, History and Forecast 2018-2029, Breakdown Data by Manufacturers, Key Regions, Types and Application

Industry: Pharma & Healthcare

Published: 2023-05-26

Pages: 109 Pages

Report ld: 1217788

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Antimicrobial peptides (AMPs), also called host defense peptides (HDPs) are part of the innate immune response found among all classes of life. Fundamental differences exist between prokaryotic and eukaryotic cells that may represent targets for antimicrobial peptides. These peptides are potent, broad spectrum antibiotics which demonstrate potential as novel therapeutic agents. Antimicrobial peptides have been demonstrated to kill Gram negative and Gram positive bacteria, enveloped viruses, fungi and even transformed or cancerous cells. Unlike the majority of conventional antibiotics it appears that antimicrobial peptides frequently destabilize biological membranes, can form transmembrane channels, and may also have the ability to enhance immunity by functioning as immunomodulators.

Antimicrobial Peptides report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Antimicrobial Peptides market is projected to reach US$ 7 million in 2029, increasing from US$ 5 million in 2022, with the CAGR of 5.4% during the period of 2023 to 2029. Demand from Pharmaceuticals and Feed Additives are the major drivers for the industry.

The major players in the industry are AnaSpec, AMP Biotech, Phoenix Biotech and Novabiotics, with revenues of about 7%, 9%, 3% and about 26% respectively in 2019. 
By region, North America had the highest share of sales, at about 35%.

Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Antimicrobial Peptides market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

Manufacturers, Type, Application and Regions Listed in the Report:
By Company
    AnaSpec
    AMP Biotech
    Phoenix Biotech
    Novabiotics
    Chinese Peptide
    Ontores
    GenScript
    Hycult Biotech
    Sunsmile
    Ruixing Biotechnology
    Zhongnong Yingtai Biotechnology
    Glam Technology
    ProteLight Pharmaceutical & Biotechnology

Segment by Type
    Plant Antimicrobial Peptides
    Microbial Antimicrobial Peptides
    Animal Antimicrobial Peptides

Segment by Application
    Pharmaceuticals
    Feed Additives
    Others

Segment by Region
    North America
        U.S.
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Asia-Pacific
        China
        Japan
        South Korea
        India
        Australia
        Taiwan
        Indonesia
        Thailand
        Malaysia
        Philippines
        Vietnam
    Latin America
        Mexico
        Brazil
        Argentina
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE

Each chapter of the report provides detailed information for readers to understand the Antimicrobial Peptides market further:
Chapter 1: Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 2: Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Antimicrobial Peptides, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Antimicrobial Peptides industry.
Chapter 3: Historical (2018-2022) and forecast (2023-2029) volume and revenue analysis of Antimicrobial Peptides in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4: Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 5 to 9: Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10: Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Antimicrobial Peptides introduction, etc. Antimicrobial Peptides Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11: Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12: Market Channel, Distributors and Customers are listed.
Chapter 13: QYResearch’s Conclusions of Antimicrobial Peptides market based on comprehensive survey.
Chapter 14: Methodology and Data Sources adopted by QYResearch.

 1 Antimicrobial Peptides Market Overview
    1.1 Antimicrobial Peptides Product Overview
    1.2 Antimicrobial Peptides Market Segment by Type
        1.2.1 Plant Antimicrobial Peptides
        1.2.2 Microbial Antimicrobial Peptides
        1.2.3 Animal Antimicrobial Peptides
    1.3 Global Antimicrobial Peptides Market Size by Type
        1.3.1 Global Antimicrobial Peptides Market Size Overview by Type (2018-2029)
        1.3.2 Global Antimicrobial Peptides Historic Market Size Review by Type (2018-2023)
        1.3.3 Global Antimicrobial Peptides Forecasted Market Size by Type (2024-2029)
    1.4 Key Regions Market Size Segment by Type
        1.4.1 North America Antimicrobial Peptides Sales Breakdown by Type (2018-2023)
        1.4.2 Europe Antimicrobial Peptides Sales Breakdown by Type (2018-2023)
        1.4.3 Asia-Pacific Antimicrobial Peptides Sales Breakdown by Type (2018-2023)
        1.4.4 Latin America Antimicrobial Peptides Sales Breakdown by Type (2018-2023)
        1.4.5 Middle East and Africa Antimicrobial Peptides Sales Breakdown by Type (2018-2023)

 2 Global Antimicrobial Peptides Market Competition by Company
    2.1 Global Top Players by Antimicrobial Peptides Sales (2018-2023)
    2.2 Global Top Players by Antimicrobial Peptides Revenue (2018-2023)
    2.3 Global Top Players by Antimicrobial Peptides Price (2018-2023)
    2.4 Global Top Manufacturers Antimicrobial Peptides Manufacturing Base Distribution, Sales Area, Product Type
    2.5 Antimicrobial Peptides Market Competitive Situation and Trends
        2.5.1 Antimicrobial Peptides Market Concentration Rate (2018-2023)
        2.5.2 Global 5 and 10 Largest Manufacturers by Antimicrobial Peptides Sales and Revenue in 2022
    2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Antimicrobial Peptides as of 2022)
    2.7 Date of Key Manufacturers Enter into Antimicrobial Peptides Market
    2.8 Key Manufacturers Antimicrobial Peptides Product Offered
    2.9 Mergers & Acquisitions, Expansion

 3 Antimicrobial Peptides Status and Outlook by Region
    3.1 Global Antimicrobial Peptides Market Size and CAGR by Region: 2018 VS 2022 VS 2029
    3.2 Global Antimicrobial Peptides Historic Market Size by Region
        3.2.1 Global Antimicrobial Peptides Sales in Volume by Region (2018-2023)
        3.2.2 Global Antimicrobial Peptides Sales in Value by Region (2018-2023)
        3.2.3 Global Antimicrobial Peptides Sales (Volume & Value) Price and Gross Margin (2018-2023)
    3.3 Global Antimicrobial Peptides Forecasted Market Size by Region
        3.3.1 Global Antimicrobial Peptides Sales in Volume by Region (2024-2029)
        3.3.2 Global Antimicrobial Peptides Sales in Value by Region (2024-2029)
        3.3.3 Global Antimicrobial Peptides Sales (Volume & Value), Price and Gross Margin (2024-2029)

 4 Global Antimicrobial Peptides by Application
    4.1 Antimicrobial Peptides Market Segment by Application
        4.1.1 Pharmaceuticals
        4.1.2 Feed Additives
        4.1.3 Others
    4.2 Global Antimicrobial Peptides Market Size by Application
        4.2.1 Global Antimicrobial Peptides Market Size Overview by Application (2018-2029)
        4.2.2 Global Antimicrobial Peptides Historic Market Size Review by Application (2018-2023)
        4.2.3 Global Antimicrobial Peptides Forecasted Market Size by Application (2024-2029)
    4.3 Key Regions Market Size Segment by Application
        4.3.1 North America Antimicrobial Peptides Sales Breakdown by Application (2018-2023)
        4.3.2 Europe Antimicrobial Peptides Sales Breakdown by Application (2018-2023)
        4.3.3 Asia-Pacific Antimicrobial Peptides Sales Breakdown by Application (2018-2023)
        4.3.4 Latin America Antimicrobial Peptides Sales Breakdown by Application (2018-2023)
        4.3.5 Middle East and Africa Antimicrobial Peptides Sales Breakdown by Application (2018-2023)

 5 North America Antimicrobial Peptides by Country
    5.1 North America Antimicrobial Peptides Historic Market Size by Country
        5.1.1 North America Antimicrobial Peptides Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
        5.1.2 North America Antimicrobial Peptides Sales in Volume by Country (2018-2023)
        5.1.3 North America Antimicrobial Peptides Sales in Value by Country (2018-2023)
    5.2 North America Antimicrobial Peptides Forecasted Market Size by Country
        5.2.1 North America Antimicrobial Peptides Sales in Volume by Country (2024-2029)
        5.2.2 North America Antimicrobial Peptides Sales in Value by Country (2024-2029)

 6 Europe Antimicrobial Peptides by Country
    6.1 Europe Antimicrobial Peptides Historic Market Size by Country
        6.1.1 Europe Antimicrobial Peptides Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
        6.1.2 Europe Antimicrobial Peptides Sales in Volume by Country (2018-2023)
        6.1.3 Europe Antimicrobial Peptides Sales in Value by Country (2018-2023)
    6.2 Europe Antimicrobial Peptides Forecasted Market Size by Country
        6.2.1 Europe Antimicrobial Peptides Sales in Volume by Country (2024-2029)
        6.2.2 Europe Antimicrobial Peptides Sales in Value by Country (2024-2029)

 7 Asia-Pacific Antimicrobial Peptides by Region
    7.1 Asia-Pacific Antimicrobial Peptides Historic Market Size by Region
        7.1.1 Asia-Pacific Antimicrobial Peptides Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
        7.1.2 Asia-Pacific Antimicrobial Peptides Sales in Volume by Region (2018-2023)
        7.1.3 Asia-Pacific Antimicrobial Peptides Sales in Value by Region (2018-2023)
    7.2 Asia-Pacific Antimicrobial Peptides Forecasted Market Size by Region
        7.2.1 Asia-Pacific Antimicrobial Peptides Sales in Volume by Region (2024-2029)
        7.2.2 Asia-Pacific Antimicrobial Peptides Sales in Value by Region (2024-2029)

 8 Latin America Antimicrobial Peptides by Country
    8.1 Latin America Antimicrobial Peptides Historic Market Size by Country
        8.1.1 Latin America Antimicrobial Peptides Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
        8.1.2 Latin America Antimicrobial Peptides Sales in Volume by Country (2018-2023)
        8.1.3 Latin America Antimicrobial Peptides Sales in Value by Country (2018-2023)
    8.2 Latin America Antimicrobial Peptides Forecasted Market Size by Country
        8.2.1 Latin America Antimicrobial Peptides Sales in Volume by Country (2024-2029)
        8.2.2 Latin America Antimicrobial Peptides Sales in Value by Country (2024-2029)

 9 Middle East and Africa Antimicrobial Peptides by Country
    9.1 Middle East and Africa Antimicrobial Peptides Historic Market Size by Country
        9.1.1 Middle East and Africa Antimicrobial Peptides Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
        9.1.2 Middle East and Africa Antimicrobial Peptides Sales in Volume by Country (2018-2023)
        9.1.3 Middle East and Africa Antimicrobial Peptides Sales in Value by Country (2018-2023)
    9.2 Middle East and Africa Antimicrobial Peptides Forecasted Market Size by Country
        9.2.1 Middle East and Africa Antimicrobial Peptides Sales in Volume by Country (2024-2029)
        9.2.2 Middle East and Africa Antimicrobial Peptides Sales in Value by Country (2024-2029)

 10 Company Profiles
    10.1 AnaSpec
        10.1.1 AnaSpec Company Information
        10.1.2 AnaSpec Introduction and Business Overview
        10.1.3 AnaSpec Antimicrobial Peptides Sales, Revenue and Gross Margin (2018-2023)
        10.1.4 AnaSpec Antimicrobial Peptides Products Offered
        10.1.5 AnaSpec Recent Development
    10.2 AMP Biotech
        10.2.1 AMP Biotech Company Information
        10.2.2 AMP Biotech Introduction and Business Overview
        10.2.3 AMP Biotech Antimicrobial Peptides Sales, Revenue and Gross Margin (2018-2023)
        10.2.4 AMP Biotech Antimicrobial Peptides Products Offered
        10.2.5 AMP Biotech Recent Development
    10.3 Phoenix Biotech
        10.3.1 Phoenix Biotech Company Information
        10.3.2 Phoenix Biotech Introduction and Business Overview
        10.3.3 Phoenix Biotech Antimicrobial Peptides Sales, Revenue and Gross Margin (2018-2023)
        10.3.4 Phoenix Biotech Antimicrobial Peptides Products Offered
        10.3.5 Phoenix Biotech Recent Development
    10.4 Novabiotics
        10.4.1 Novabiotics Company Information
        10.4.2 Novabiotics Introduction and Business Overview
        10.4.3 Novabiotics Antimicrobial Peptides Sales, Revenue and Gross Margin (2018-2023)
        10.4.4 Novabiotics Antimicrobial Peptides Products Offered
        10.4.5 Novabiotics Recent Development
    10.5 Chinese Peptide
        10.5.1 Chinese Peptide Company Information
        10.5.2 Chinese Peptide Introduction and Business Overview
        10.5.3 Chinese Peptide Antimicrobial Peptides Sales, Revenue and Gross Margin (2018-2023)
        10.5.4 Chinese Peptide Antimicrobial Peptides Products Offered
        10.5.5 Chinese Peptide Recent Development
    10.6 Ontores
        10.6.1 Ontores Company Information
        10.6.2 Ontores Introduction and Business Overview
        10.6.3 Ontores Antimicrobial Peptides Sales, Revenue and Gross Margin (2018-2023)
        10.6.4 Ontores Antimicrobial Peptides Products Offered
        10.6.5 Ontores Recent Development
    10.7 GenScript
        10.7.1 GenScript Company Information
        10.7.2 GenScript Introduction and Business Overview
        10.7.3 GenScript Antimicrobial Peptides Sales, Revenue and Gross Margin (2018-2023)
        10.7.4 GenScript Antimicrobial Peptides Products Offered
        10.7.5 GenScript Recent Development
    10.8 Hycult Biotech
        10.8.1 Hycult Biotech Company Information
        10.8.2 Hycult Biotech Introduction and Business Overview
        10.8.3 Hycult Biotech Antimicrobial Peptides Sales, Revenue and Gross Margin (2018-2023)
        10.8.4 Hycult Biotech Antimicrobial Peptides Products Offered
        10.8.5 Hycult Biotech Recent Development
    10.9 Sunsmile
        10.9.1 Sunsmile Company Information
        10.9.2 Sunsmile Introduction and Business Overview
        10.9.3 Sunsmile Antimicrobial Peptides Sales, Revenue and Gross Margin (2018-2023)
        10.9.4 Sunsmile Antimicrobial Peptides Products Offered
        10.9.5 Sunsmile Recent Development
    10.10 Ruixing Biotechnology
        10.10.1 Ruixing Biotechnology Company Information
        10.10.2 Ruixing Biotechnology Introduction and Business Overview
        10.10.3 Ruixing Biotechnology Antimicrobial Peptides Sales, Revenue and Gross Margin (2018-2023)
        10.10.4 Ruixing Biotechnology Antimicrobial Peptides Products Offered
        10.10.5 Ruixing Biotechnology Recent Development
    10.11 Zhongnong Yingtai Biotechnology
        10.11.1 Zhongnong Yingtai Biotechnology Company Information
        10.11.2 Zhongnong Yingtai Biotechnology Introduction and Business Overview
        10.11.3 Zhongnong Yingtai Biotechnology Antimicrobial Peptides Sales, Revenue and Gross Margin (2018-2023)
        10.11.4 Zhongnong Yingtai Biotechnology Antimicrobial Peptides Products Offered
        10.11.5 Zhongnong Yingtai Biotechnology Recent Development
    10.12 Glam Technology
        10.12.1 Glam Technology Company Information
        10.12.2 Glam Technology Introduction and Business Overview
        10.12.3 Glam Technology Antimicrobial Peptides Sales, Revenue and Gross Margin (2018-2023)
        10.12.4 Glam Technology Antimicrobial Peptides Products Offered
        10.12.5 Glam Technology Recent Development
    10.13 ProteLight Pharmaceutical & Biotechnology
        10.13.1 ProteLight Pharmaceutical & Biotechnology Company Information
        10.13.2 ProteLight Pharmaceutical & Biotechnology Introduction and Business Overview
        10.13.3 ProteLight Pharmaceutical & Biotechnology Antimicrobial Peptides Sales, Revenue and Gross Margin (2018-2023)
        10.13.4 ProteLight Pharmaceutical & Biotechnology Antimicrobial Peptides Products Offered
        10.13.5 ProteLight Pharmaceutical & Biotechnology Recent Development

 11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
    11.1 Antimicrobial Peptides Key Raw Materials
        11.1.1 Key Raw Materials
        11.1.2 Key Raw Materials Price
        11.1.3 Raw Materials Key Suppliers
    11.2 Manufacturing Cost Structure
        11.2.1 Raw Materials
        11.2.2 Labor Cost
        11.2.3 Manufacturing Expenses
    11.3 Antimicrobial Peptides Industrial Chain Analysis
    11.4 Antimicrobial Peptides Market Dynamics
        11.4.1 Antimicrobial Peptides Industry Trends
        11.4.2 Antimicrobial Peptides Market Drivers
        11.4.3 Antimicrobial Peptides Market Challenges
        11.4.4 Antimicrobial Peptides Market Restraints

 12 Market Strategy Analysis, Distributors
    12.1 Sales Channel
    12.2 Antimicrobial Peptides Distributors
    12.3 Antimicrobial Peptides Downstream Customers

 13 Research Findings and Conclusion

 14 Appendix
    14.1 Research Methodology
        14.1.1 Methodology/Research Approach
        14.1.2 Data Source
    14.2 Author Details
    14.3 Disclaimer

List of Tables
    Table 1. Major Company of Plant Antimicrobial Peptides
    Table 2. Major Company of Microbial Antimicrobial Peptides
    Table 3. Major Company of Animal Antimicrobial Peptides
    Table 4. Global Antimicrobial Peptides Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
    Table 5. Global Antimicrobial Peptides Sales by Type (2018-2023) & (Mg)
    Table 6. Global Antimicrobial Peptides Sales Market Share in Volume by Type (2018-2023)
    Table 7. Global Antimicrobial Peptides Sales by Type (2018-2023) & (US& Million)
    Table 8. Global Antimicrobial Peptides Market Share in Value by Type (2018-2023)
    Table 9. Global Antimicrobial Peptides Price by Type (2018-2023) & (US$/Mg)
    Table 10. Global Antimicrobial Peptides Sales by Type (2024-2029) & (Mg)
    Table 11. Global Antimicrobial Peptides Sales Market Share in Volume by Type (2024-2029)
    Table 12. Global Antimicrobial Peptides Sales by Type (2024-2029) & (US$ Million)
    Table 13. Global Antimicrobial Peptides Sales Market Share in Value by Type (2024-2029)
    Table 14. Global Antimicrobial Peptides Price by Type (2024-2029) & (US$/Mg)
    Table 15. North America Antimicrobial Peptides Sales by Type (2018-2023) & (Mg)
    Table 16. North America Antimicrobial Peptides Sales by Type (2018-2023) & (US$ Million)
    Table 17. Europe Antimicrobial Peptides Sales (Mg) by Type (2018-2023)
    Table 18. Europe Antimicrobial Peptides Sales by Type (2018-2023) & (US$ Million)
    Table 19. Asia-Pacific Antimicrobial Peptides Sales (Mg) by Type (2018-2023)
    Table 20. Asia-Pacific Antimicrobial Peptides Sales by Type (2018-2023) & (US$ Million)
    Table 21. Latin America Antimicrobial Peptides Sales (Mg) by Type (2018-2023)
    Table 22. Latin America Antimicrobial Peptides Sales by Type (2018-2023) & (US$ Million)
    Table 23. Middle East and Africa Antimicrobial Peptides Sales (Mg) by Type (2018-2023)
    Table 24. Middle East and Africa Antimicrobial Peptides Sales by Type (2018-2023) & (US$ Million)
    Table 25. Global Antimicrobial Peptides Sales by Company (2018-2023) & (Mg)
    Table 26. Global Antimicrobial Peptides Sales Share by Company (2018-2023)
    Table 27. Global Antimicrobial Peptides Revenue by Company (2018-2023) & (US$ Million)
    Table 28. Global Antimicrobial Peptides Revenue Share by Company (2018-2023)
    Table 29. Global Market Antimicrobial Peptides Price by Company (2018-2023) & (US$/Mg)
    Table 30. Global Antimicrobial Peptides Top Manufacturers Manufacturing Base Distribution and Sales Area
    Table 31. Global Antimicrobial Peptides Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 32. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Antimicrobial Peptides as of 2022)
    Table 33. Date of Key Manufacturers Enter into Antimicrobial Peptides Market
    Table 34. Key Manufacturers Antimicrobial Peptides Product Type
    Table 35. Mergers & Acquisitions, Expansion Plans
    Table 36. Global Antimicrobial Peptides Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 37. Global Antimicrobial Peptides Sales by Region (2018-2023) & (Mg)
    Table 38. Global Antimicrobial Peptides Sales Market Share in Volume by Region (2018-2023)
    Table 39. Global Antimicrobial Peptides Sales by Region (2018-2023) & (US$ Million)
    Table 40. Global Antimicrobial Peptides Sales Market Share in Value by Region (2018-2023)
    Table 41. Global Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2018-2023)
    Table 42. Global Antimicrobial Peptides Sales by Region (2024-2029) & (Mg)
    Table 43. Global Antimicrobial Peptides Sales Market Share in Volume by Region (2024-2029)
    Table 44. Global Antimicrobial Peptides Sales by Region (2024-2029) & (US$ Million)
    Table 45. Global Antimicrobial Peptides Sales Market Share in Value by Region (2024-2029)
    Table 46. Global Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2024-2029)
    Table 47. Global Antimicrobial Peptides Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
    Table 48. Global Antimicrobial Peptides Sales by Application (2018-2023) & (Mg)
    Table 49. Global Antimicrobial Peptides Sales Market Share in Volume by Application (2018-2023)
    Table 50. Global Antimicrobial Peptides Sales by Application (2018-2023) & (US$ Million)
    Table 51. Global Antimicrobial Peptides Sales Market Share in Value by Application (2018-2023)
    Table 52. Global Antimicrobial Peptides Price by Application (2018-2023) & (US$/Mg)
    Table 53. Global Antimicrobial Peptides Sales by Application (2024-2029) & (Mg)
    Table 54. Global Antimicrobial Peptides Sales Market Share in Volume by Application (2024-2029)
    Table 55. Global Antimicrobial Peptides Sales by Application (2024-2029) & (US$ Million)
    Table 56. Global Antimicrobial Peptides Sales Market Share in Value by Application (2024-2029)
    Table 57. Global Antimicrobial Peptides Price by Application (2024-2029) & (US$/Mg)
    Table 58. North America Antimicrobial Peptides Sales by Application (2018-2023) (Mg) 
    Table 59. North America Antimicrobial Peptides Sales by Application (2018-2023) & (US$ Million)
    Table 60. Europe Antimicrobial Peptides Sales by Application (2018-2023) (Mg) 
    Table 61. Europe Antimicrobial Peptides Sales by Application (2018-2023) & (US$ Million)
    Table 62. Asia-Pacific Antimicrobial Peptides Sales by Application (2018-2023) (Mg) 
    Table 63. Asia-Pacific Antimicrobial Peptides Sales by Application (2018-2023) & (US$ Million)
    Table 64. Latin America Antimicrobial Peptides Sales by Application (2018-2023) (Mg) 
    Table 65. Latin America Antimicrobial Peptides Sales by Application (2018-2023) & (US$ Million)
    Table 66. Middle East and Africa Antimicrobial Peptides Sales by Application (2018-2023) (Mg) 
    Table 67. Middle East and Africa Antimicrobial Peptides Sales by Application (2018-2023) & (US$ Million)
    Table 68. North America Antimicrobial Peptides Sales by Country (2018-2023) & (Mg)
    Table 69. North America Antimicrobial Peptides Sales Market Share in Volume by Country (2018-2023)
    Table 70. North America Antimicrobial Peptides Sales by Country (2018-2023) & (US$ Million)
    Table 71. North America Antimicrobial Peptides Sales Market Share in Value by Country (2018-2023)
    Table 72. North America Antimicrobial Peptides Sales by Country (2024-2029) & (Mg)
    Table 73. North America Antimicrobial Peptides Sales Market Share in Volume by Country (2024-2029)
    Table 74. North America Antimicrobial Peptides Sales by Country (2024-2029) & (US$ Million)
    Table 75. North America Antimicrobial Peptides Sales Market Share in Value by Country (2024-2029)
    Table 76. Europe Antimicrobial Peptides Sales by Country (2018-2023) & (Mg)
    Table 77. Europe Antimicrobial Peptides Sales Market Share in Volume by Country (2018-2023)
    Table 78. Europe Antimicrobial Peptides Sales by Country (2018-2023) & (US$ Million)
    Table 79. Europe Antimicrobial Peptides Sales Market Share in Value by Country (2018-2023)
    Table 80. Europe Antimicrobial Peptides Sales by Country (2024-2029) & (Mg)
    Table 81. Europe Antimicrobial Peptides Sales Market Share in Volume by Country (2024-2029)
    Table 82. Europe Antimicrobial Peptides Sales by Country (2024-2029) & (US$ Million)
    Table 83. Europe Antimicrobial Peptides Sales Market Share in Value by Country (2024-2029)
    Table 84. Asia-Pacific Antimicrobial Peptides Sales by Region (2018-2023) & (Mg)
    Table 85. Asia-Pacific Antimicrobial Peptides Sales Market Share in Volume by Region (2018-2023)
    Table 86. Asia-Pacific Antimicrobial Peptides Sales by Region (2018-2023) & (US$ Million)
    Table 87. Asia-Pacific Antimicrobial Peptides Sales Market Share in Value by Region (2018-2023)
    Table 88. Asia-Pacific Antimicrobial Peptides Sales by Region (2024-2029) & (Mg)
    Table 89. Asia-Pacific Antimicrobial Peptides Sales Market Share in Volume by Region (2024-2029)
    Table 90. Asia-Pacific Antimicrobial Peptides Sales by Region (2024-2029) & (US$ Million)
    Table 91. Asia-Pacific Antimicrobial Peptides Sales Market Share in Value by Region (2024-2029)
    Table 92. Latin America Antimicrobial Peptides Sales by Country (2018-2023) & (Mg)
    Table 93. Latin America Antimicrobial Peptides Sales Market Share in Volume by Country (2018-2023)
    Table 94. Latin America Antimicrobial Peptides Sales by Country (2018-2023) & (US$ Million)
    Table 95. Latin America Antimicrobial Peptides Sales Market Share in Value by Country (2018-2023)
    Table 96. Latin America Antimicrobial Peptides Sales by Country (2024-2029) & (Mg)
    Table 97. Latin America Antimicrobial Peptides Sales Market Share in Volume by Country (2024-2029)
    Table 98. Latin America Antimicrobial Peptides Sales by Country (2024-2029) & (US$ Million)
    Table 99. Latin America Antimicrobial Peptides Sales Market Share in Value by Country (2024-2029)
    Table 100. Middle East and Africa Antimicrobial Peptides Sales by Country (2018-2023) & (Mg)
    Table 101. Middle East and Africa Antimicrobial Peptides Sales Market Share in Volume by Country (2018-2023)
    Table 102. Middle East and Africa Antimicrobial Peptides Sales by Country (2018-2023) & (US$ Million)
    Table 103. Middle East and Africa Antimicrobial Peptides Sales Market Share in Value by Country (2018-2023)
    Table 104. Middle East and Africa Antimicrobial Peptides Sales by Country (2024-2029) & (Mg)
    Table 105. Middle East and Africa Antimicrobial Peptides Sales Market Share in Volume by Country (2024-2029)
    Table 106. Middle East and Africa Antimicrobial Peptides Sales by Country (2024-2029) & (US$ Million)
    Table 107. Middle East and Africa Antimicrobial Peptides Sales Market Share in Value by Country (2024-2029)
    Table 108. AnaSpec Company Information
    Table 109. AnaSpec Introduction and Business Overview
    Table 110. AnaSpec Antimicrobial Peptides Sales (Mg), Revenue (Million USD), Price (US$/Mg) and Gross Margin (2018-2023)
    Table 111. AnaSpec Antimicrobial Peptides Product
    Table 112. AnaSpec Recent Development
    Table 113. AMP Biotech Company Information
    Table 114. AMP Biotech Introduction and Business Overview
    Table 115. AMP Biotech Antimicrobial Peptides Sales (Mg), Revenue (Million USD), Price (US$/Mg) and Gross Margin (2018-2023)
    Table 116. AMP Biotech Antimicrobial Peptides Product
    Table 117. AMP Biotech Recent Development
    Table 118. Phoenix Biotech Company Information
    Table 119. Phoenix Biotech Introduction and Business Overview
    Table 120. Phoenix Biotech Antimicrobial Peptides Sales (Mg), Revenue (Million USD), Price (US$/Mg) and Gross Margin (2018-2023)
    Table 121. Phoenix Biotech Antimicrobial Peptides Product
    Table 122. Phoenix Biotech Recent Development
    Table 123. Novabiotics Company Information
    Table 124. Novabiotics Introduction and Business Overview
    Table 125. Novabiotics Antimicrobial Peptides Sales (Mg), Revenue (Million USD), Price (US$/Mg) and Gross Margin (2018-2023)
    Table 126. Novabiotics Antimicrobial Peptides Product
    Table 127. Novabiotics Recent Development
    Table 128. Chinese Peptide Company Information
    Table 129. Chinese Peptide Introduction and Business Overview
    Table 130. Chinese Peptide Antimicrobial Peptides Sales (Mg), Revenue (Million USD), Price (US$/Mg) and Gross Margin (2018-2023)
    Table 131. Chinese Peptide Antimicrobial Peptides Product
    Table 132. Chinese Peptide Recent Development
    Table 133. Ontores Company Information
    Table 134. Ontores Introduction and Business Overview
    Table 135. Ontores Antimicrobial Peptides Sales (Mg), Revenue (Million USD), Price (US$/Mg) and Gross Margin (2018-2023)
    Table 136. Ontores Antimicrobial Peptides Product
    Table 137. Ontores Recent Development
    Table 138. GenScript Company Information
    Table 139. GenScript Introduction and Business Overview
    Table 140. GenScript Antimicrobial Peptides Sales (Mg), Revenue (Million USD), Price (US$/Mg) and Gross Margin (2018-2023)
    Table 141. GenScript Antimicrobial Peptides Product
    Table 142. GenScript Recent Development
    Table 143. Hycult Biotech Company Information
    Table 144. Hycult Biotech Introduction and Business Overview
    Table 145. Hycult Biotech Antimicrobial Peptides Sales (Mg), Revenue (Million USD), Price (US$/Mg) and Gross Margin (2018-2023)
    Table 146. Hycult Biotech Antimicrobial Peptides Product
    Table 147. Hycult Biotech Recent Development
    Table 148. Sunsmile Company Information
    Table 149. Sunsmile Introduction and Business Overview
    Table 150. Sunsmile Antimicrobial Peptides Sales (Mg), Revenue (Million USD), Price (US$/Mg) and Gross Margin (2018-2023)
    Table 151. Sunsmile Antimicrobial Peptides Product
    Table 152. Sunsmile Recent Development
    Table 153. Ruixing Biotechnology Company Information
    Table 154. Ruixing Biotechnology Introduction and Business Overview
    Table 155. Ruixing Biotechnology Antimicrobial Peptides Sales (Mg), Revenue (Million USD), Price (US$/Mg) and Gross Margin (2018-2023)
    Table 156. Ruixing Biotechnology Antimicrobial Peptides Product
    Table 157. Ruixing Biotechnology Recent Development
    Table 158. Zhongnong Yingtai Biotechnology Company Information
    Table 159. Zhongnong Yingtai Biotechnology Introduction and Business Overview
    Table 160. Zhongnong Yingtai Biotechnology Antimicrobial Peptides Sales (Mg), Revenue (Million USD), Price (US$/Mg) and Gross Margin (2018-2023)
    Table 161. Zhongnong Yingtai Biotechnology Antimicrobial Peptides Product
    Table 162. Zhongnong Yingtai Biotechnology Recent Development
    Table 163. Glam Technology Company Information
    Table 164. Glam Technology Introduction and Business Overview
    Table 165. Glam Technology Antimicrobial Peptides Sales (Mg), Revenue (Million USD), Price (US$/Mg) and Gross Margin (2018-2023)
    Table 166. Glam Technology Antimicrobial Peptides Product
    Table 167. Glam Technology Recent Development
    Table 168. ProteLight Pharmaceutical & Biotechnology Company Information
    Table 169. ProteLight Pharmaceutical & Biotechnology Introduction and Business Overview
    Table 170. ProteLight Pharmaceutical & Biotechnology Antimicrobial Peptides Sales (Mg), Revenue (Million USD), Price (US$/Mg) and Gross Margin (2018-2023)
    Table 171. ProteLight Pharmaceutical & Biotechnology Antimicrobial Peptides Product
    Table 172. ProteLight Pharmaceutical & Biotechnology Recent Development
    Table 173. Key Raw Materials Lists
    Table 174. Raw Materials Key Suppliers Lists
    Table 175. Antimicrobial Peptides Market Trends
    Table 176. Antimicrobial Peptides Market Drivers
    Table 177. Antimicrobial Peptides Market Challenges
    Table 178. Antimicrobial Peptides Market Restraints
    Table 179. Antimicrobial Peptides Distributors List
    Table 180. Antimicrobial Peptides Downstream Customers
    Table 181. Research Programs/Design for This Report
    Table 182. Key Data Information from Secondary Sources
    Table 183. Key Data Information from Primary Sources
List of Figures
    Figure 1. Antimicrobial Peptides Product Picture
    Figure 2. Global Antimicrobial Peptides Market Size, 2018 VS 2022 VS 2029 (US$ Million)
    Figure 3. Global Antimicrobial Peptides Market Size Status and Outlook (2018-2029) & (US$ Million)
    Figure 4. Global Antimicrobial Peptides Sales Status and Outlook (2018-2029) & (Mg)
    Figure 5. Product Picture of Plant Antimicrobial Peptides
    Figure 6. Global Plant Antimicrobial Peptides Sales YoY Growth (2018-2029) & (Mg)
    Figure 7. Product Picture of Microbial Antimicrobial Peptides
    Figure 8. Global Microbial Antimicrobial Peptides Sales YoY Growth (2018-2029) & (Mg)
    Figure 9. Product Picture of Animal Antimicrobial Peptides
    Figure 10. Global Animal Antimicrobial Peptides Sales YoY Growth (2018-2029) & (Mg)
    Figure 11. Global Antimicrobial Peptides Sales by Type (2018-2029) & (US$ Million)
    Figure 12. Global Antimicrobial Peptides Sales Market Share by Type in 2022 & 2029
    Figure 13. North America Antimicrobial Peptides Sales Market Share in Volume by Type in 2022
    Figure 14. North America Antimicrobial Peptides Sales Market Share in Value by Type in 2022
    Figure 15. Europe Antimicrobial Peptides Sales Market Share in Volume by Type in 2022
    Figure 16. Europe Antimicrobial Peptides Sales Market Share in Value by Type in 2022
    Figure 17. Asia-Pacific Antimicrobial Peptides Sales Market Share in Volume by Type in 2022
    Figure 18. Asia-Pacific Antimicrobial Peptides Sales Market Share in Value by Type in 2022
    Figure 19. Latin America Antimicrobial Peptides Sales Market Share in Volume by Type in 2022
    Figure 20. Latin America Antimicrobial Peptides Sales Market Share in Value by Type in 2022
    Figure 21. Middle East and Africa Antimicrobial Peptides Sales Market Share in Volume by Type in 2022
    Figure 22. Middle East and Africa Antimicrobial Peptides Sales Market Share in Value by Type in 2022
    Figure 23. The 5 and 10 Largest Manufacturers in the World: Market Share by Antimicrobial Peptides Sales in 2022
    Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by Antimicrobial Peptides Revenue in 2022
    Figure 25. Antimicrobial Peptides Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
    Figure 26. Product Picture of Pharmaceuticals
    Figure 27. Global Pharmaceuticals Sales YoY Growth (2018-2029) & (Mg)
    Figure 28. Product Picture of Feed Additives
    Figure 29. Global Feed Additives Sales YoY Growth (2018-2029) & (Mg)
    Figure 30. Product Picture of Others
    Figure 31. Global Others Sales YoY Growth (2018-2029) & (Mg)
    Figure 32. Global Antimicrobial Peptides Sales by Application (2018-2029) & (US$ Million)
    Figure 33. Global Antimicrobial Peptides Sales Market Share by Application in 2022 & 2029
    Figure 34. North America Antimicrobial Peptides Sales Market Share in Volume by Application in 2022
    Figure 35. North America Antimicrobial Peptides Sales Market Share in Value by Application in 2022
    Figure 36. Europe Antimicrobial Peptides Sales Market Share in Volume by Application in 2022
    Figure 37. Europe Antimicrobial Peptides Sales Market Share in Value by Application in 2022
    Figure 38. Asia-Pacific Antimicrobial Peptides Sales Market Share in Volume by Application in 2022
    Figure 39. Asia-Pacific Antimicrobial Peptides Sales Market Share in Value by Application in 2022
    Figure 40. Latin America Antimicrobial Peptides Sales Market Share in Volume by Application in 2022
    Figure 41. Latin America Antimicrobial Peptides Sales Market Share in Value by Application in 2022
    Figure 42. Middle East and Africa Antimicrobial Peptides Sales Market Share in Value by Application in 2022
    Figure 43. Key Raw Materials Price
    Figure 44. Antimicrobial Peptides Manufacturing Cost Structure
    Figure 45. Antimicrobial Peptides Industrial Chain Analysis
    Figure 46. Channels of Distribution
    Figure 47. Distributors Profiles
    Figure 48. Bottom-up and Top-down Approaches for This Report
    Figure 49. Data Triangulation
    Figure 50. Key Executives Interviewed

Antimicrobial peptides (AMPs), also called host defense peptides (HDPs) are part of the innate immune response found among all classes of life. Fundamental differences exist between prokaryotic and eukaryotic cells that may represent targets for antimicrobial peptides. These peptides are potent, broad spectrum antibiotics which demonstrate potential as novel therapeutic agents. Antimicrobial peptides have been demonstrated to kill Gram negative and Gram positive bacteria, enveloped viruses, fungi and even transformed or cancerous cells. Unlike the majority of conventional antibiotics it appears that antimicrobial peptides frequently destabilize biological membranes, can form transmembrane channels, and may also have the ability to enhance immunity by functioning as immunomodulators.

Antimicrobial Peptides report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Antimicrobial Peptides market is projected to reach US$ 7 million in 2029, increasing from US$ 5 million in 2022, with the CAGR of 5.4% during the period of 2023 to 2029. Demand from Pharmaceuticals and Feed Additives are the major drivers for the industry.

The major players in the industry are AnaSpec, AMP Biotech, Phoenix Biotech and Novabiotics, with revenues of about 7%, 9%, 3% and about 26% respectively in 2019. 
By region, North America had the highest share of sales, at about 35%.

Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Antimicrobial Peptides market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

Manufacturers, Type, Application and Regions Listed in the Report:
By Company
    AnaSpec
    AMP Biotech
    Phoenix Biotech
    Novabiotics
    Chinese Peptide
    Ontores
    GenScript
    Hycult Biotech
    Sunsmile
    Ruixing Biotechnology
    Zhongnong Yingtai Biotechnology
    Glam Technology
    ProteLight Pharmaceutical & Biotechnology

Segment by Type
    Plant Antimicrobial Peptides
    Microbial Antimicrobial Peptides
    Animal Antimicrobial Peptides

Segment by Application
    Pharmaceuticals
    Feed Additives
    Others

Segment by Region
    North America
        U.S.
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Asia-Pacific
        China
        Japan
        South Korea
        India
        Australia
        Taiwan
        Indonesia
        Thailand
        Malaysia
        Philippines
        Vietnam
    Latin America
        Mexico
        Brazil
        Argentina
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE

Each chapter of the report provides detailed information for readers to understand the Antimicrobial Peptides market further:
Chapter 1: Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 2: Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Antimicrobial Peptides, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Antimicrobial Peptides industry.
Chapter 3: Historical (2018-2022) and forecast (2023-2029) volume and revenue analysis of Antimicrobial Peptides in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4: Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 5 to 9: Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10: Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Antimicrobial Peptides introduction, etc. Antimicrobial Peptides Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11: Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12: Market Channel, Distributors and Customers are listed.
Chapter 13: QYResearch’s Conclusions of Antimicrobial Peptides market based on comprehensive survey.
Chapter 14: Methodology and Data Sources adopted by QYResearch.

Industry: Pharma & Healthcare

Published: 2023-05-26

Pages: 109 Pages

Report ld: 1217788

Request Sample

Pre-Order Enquiry

CHOOSE LICENSE TYPE

Single User License

USD 3350.00

Multi Users License

USD 5025.00

Corporate Users License